ENACT
发表于 2025-3-30 10:05:53
Treatment of Acute Nonlymphoblastic Leukemia in the Children’s Cancer and Leukemia Study Group4 patients, 82 (71.9%) achieved complete remission (CR). There was no difference in the CR rate among five different protocols proposed by CCLSG. The rates of continuous complete remission (COR.) at 20 months were 43.0 ± 10.7% (mean ± SE), 23.4 ± 11.0%, and 65.8 ± 10.6% in Regimen I, Regimen II, and
粗俗人
发表于 2025-3-30 12:52:06
http://reply.papertrans.cn/23/2252/225118/225118_52.png
PHON
发表于 2025-3-30 16:55:53
http://reply.papertrans.cn/23/2252/225118/225118_53.png
驳船
发表于 2025-3-30 21:33:22
http://reply.papertrans.cn/23/2252/225118/225118_54.png
创新
发表于 2025-3-31 04:54:58
http://reply.papertrans.cn/23/2252/225118/225118_55.png
鲁莽
发表于 2025-3-31 08:37:01
Immunological Properties of Hematopoietic Malignancies in Childhoods are tumors of early activated B cells. In LAs, 14 anaplastic large cell lymphomas (Ki-1 lymphoma) were included. Phenotypically, Ki-1(CD30), epithelial membrane antigen (EMA), HLA-DR, and the IL-2 receptor were frequently identified. The tumor cells expressed no specific T— cell (CD3/5/8) or B-cel
卵石
发表于 2025-3-31 09:21:39
http://reply.papertrans.cn/23/2252/225118/225118_57.png
高原
发表于 2025-3-31 14:41:37
http://reply.papertrans.cn/23/2252/225118/225118_58.png